GRK2158 Lectures Series

The GRK2158 lecture series is a major part of the GRK qualification program. During the first 2 semesters of the GRK a synchronization of the knowledge of the doctoral students in the field of preclinical drug discovery shall be attained. In the third and fourth semesters specialized lectures by internal and external lecturers from science, industry and public authorities will be held to get deeper insights in the individual stages of drug development.

Summer Semester 2018

The lectures will start at 4:30 pm in lecture hall 6H (Building 26.41.).

Date Topic Speaker
09.04.2018 Natural products and drug discovery Peter Proksch
23.04.2018 Chemoenzymatic natural product synthesis Jörg Pietruszka
14.05.2018 Diversity Oriented Synthesis of Bioactive Compounds by One-Pot Methodologies Thomas J.J. Müller

Winter Semester 2017/18

The lectures will take place in Building 25.22. Lecture Hall 5H starting at 4:30 pm.

Date Topic Speaker
09.10.2017 How structural biology can help to identify resistance mechanisms Sander Smits
23.10.2017 Virtual Screening Holger Gohlke
13.11.2017 Drugs effects: Basics in Pharmacokinetics and dynamics Gerhard Fritz
27.11.2017 From bench to bedside – Compound development on the example of Pitolisant, the first histamine H3 receptor antagonist on market Holger Stark
11.12.2017 Cancer Chemoresistance Matthias Kassack
15.01.2018 Development of Histone deacetylase inhibitors (metalloenzyme inhibitors) Thomas Kurz

Summer Semester 2017

The lectures will take place in Building 26.41. Lecture Hall 6H starting at 4:30 pm.

Date Topic Speaker
24.04.2017 Microbial pathogenesis and antimicrobial chemotherapy Klaus Pfeffer
15.05.2017 Microbial pathogenesis and antimicrobial chemotherapy Rainer Kalscheuer
29.05.2017 Role of Apoptosis Signaling in Tumorigenesis and Therapy Resistance Sebastian Wesselborg
19.06.2017 The Role of Autophagy in Cancer: Current Concepts and Therapeutic Implications Björn Stork
03.07.2017 On the way to personalized tumor therapy Rainer Haas
17.07.2017 Immune response against microorganisms and tumors Stefanie Scheu


Responsible for the content: E-MailMartina Holz